ClinConnect ClinConnect Logo
Search / Trial NCT07016386

Ultrasound-guided Interscalene Block Versus Infraspinatus-Teres Minor Plane Block in Shoulder Arthroscopy

Launched by MISR UNIVERSITY FOR SCIENCE AND TECHNOLOGY · Jun 3, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Ultrasound Guided, Interscaline Block, Versus Infraspinatus Teres Minor Block Shoulder Arthroscopy.

ClinConnect Summary

This clinical trial is studying two different methods of pain relief for patients undergoing shoulder arthroscopy, which is a type of surgery on the shoulder. The researchers want to find out which method works better and is safer: the Interscalene block (ISB) or the Infraspinatus-Teres minor (ITM) block. Both techniques involve using ultrasound to guide the injection of anesthetic medication to help manage pain after the surgery.

The trial will include 46 patients aged between 20 and 70 who are generally healthy and scheduled for this type of surgery. Participants will be randomly assigned to one of the two groups before they receive general anesthesia. They will be monitored for pain relief, how long the pain relief lasts, any side effects, and their overall satisfaction after the surgery. This information will help doctors understand which pain management technique might be better for patients in the future. If you or a family member are interested in participating, you would need to meet specific health criteria and give your consent to join the study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 20 to 60,
  • ASA classification I or II,
  • scheduled for arthroscopic shoulder surgery,
  • will be randomized 1:1 into two groups before the induction of general anesthesia (GA)
  • Exclusion Criteria:
  • Patients who refuse participation.
  • Have allergies to local anesthetics.
  • Phrenic nerve dysfunction.
  • Chronic opioid use.
  • ASA III or higher classification.
  • Coagulopathy.
  • Severe chronic obstructive pulmonary disease.
  • Local infection at the injection site

About Misr University For Science And Technology

MISR University for Science and Technology is a leading institution dedicated to advancing healthcare and scientific research through innovative clinical trials. With a strong focus on interdisciplinary collaboration, the university leverages its diverse expertise to address pressing medical challenges and enhance patient outcomes. Committed to ethical research practices and regulatory compliance, MISR University fosters a robust environment for clinical investigation, aiming to contribute valuable insights to the global medical community. Through its rigorous methodologies and emphasis on scientific excellence, the university strives to translate research findings into tangible health solutions.

Locations

Giza, , Egypt

Patients applied

0 patients applied

Trial Officials

Mohammed Hany Kamal, Prof. of anesthesia and pain

Study Chair

Misr University for Science and Technolog

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported